AFFF Firefighting Foam Lawsuit: The Complete Guide
Aqueous Film-Forming Foam (AFFF) is a firefighting suppressant developed in the 1960s by the U.S. Navy and 3M. It is highly effective at extinguishing hydrocarbon fuel fires—and it contains per- and polyfluoroalkyl substances (PFAS), a class of human-made chemicals that do not break down in the environment and have been linked to multiple types of cancer. For decades, AFFF was used extensively on military bases, at airports, in fire training facilities, and by municipal fire departments across the country. As a result, hundreds of thousands of firefighters, military personnel, and residents near contaminated water sources have been exposed to PFAS at levels far exceeding safe limits. Tens of thousands of lawsuits have been consolidated into Multidistrict Litigation MDL No. 2873 in the District of South Carolina, involving firefighter plaintiffs, military service members, and individuals exposed through contaminated drinking water. This comprehensive guide covers everything you need to know about AFFF firefighting foam lawsuits, including eligibility criteria, scientific evidence, settlement amounts, the MDL timeline, and how to file a claim.
Overview
Litigation Timeline
AFFF (Aqueous Film-Forming Foam) is developed by the U.S. Navy in collaboration with 3M. The foam contains high concentrations of PFOS and PFOA, which provide superior fire-suppression capabilities but are later found to be extremely persistent environmental contaminants.
Scientific awareness of PFAS toxicity grows. 3M discovers PFOS in human blood samples globally and initiates internal studies on health effects. By 2000, 3M announces a phase-out of PFOS production. EPA begins investigating PFOA and PFOS contamination at military bases and industrial sites.
First wave of AFFF lawsuits is filed against 3M, DuPont, and other manufacturers by individuals diagnosed with cancer after occupational exposure to PFAS-containing firefighting foams. Cases allege failure to warn about health risks and contamination of drinking water supplies.
The Judicial Panel on Multidistrict Litigation establishes <strong>MDL No. 2873</strong> (In re: Aqueous Film-Forming Foams Products Liability Litigation) in the District of South Carolina, before Judge Richard M. Gergel, to coordinate all federal AFFF personal injury and water contamination lawsuits.
Bellwether trials proceed in MDL 2873. Multiple cases produce mixed verdicts, including a $50 million verdict against 3M and DuPont in 2021 for water contamination in Alabama. These bellwether outcomes provide settlement frameworks for the broader MDL docket.
3M announces a <strong>$10.3 billion settlement</strong> with public water systems to resolve PFAS drinking water contamination claims. The settlement is structured over 13 years and covers water systems that have detected PFAS at any level. Separately, DuPont and Chemours agree to a $1.19 billion settlement.
Individual personal injury claims (firefighters and military personnel with cancer) continue through MDL proceedings. Settlement frameworks are negotiated for cancer cases against settling defendants. EPA issues new PFAS drinking water Maximum Contaminant Levels (MCLs) requiring water systems to filter PFOA and PFOS to near-zero levels.
MDL 2873 continues with remaining defendants. Individual personal injury cases against 3M and DuPont/Chemours are being resolved through settlement processes. New claims continue to be filed as awareness of PFAS health effects grows. Claimants are advised to consult counsel promptly given varying state statute of limitations deadlines.
Scientific Evidence
Settlement Data & Compensation
| Tier | Range | Criteria |
|---|---|---|
| Tier 1 — Severe / Metastatic Cancer | $250,000–$750,000+ | Metastatic or late-stage kidney cancer, testicular cancer, pancreatic cancer, or liver cancer with poor prognosis; extensive chemotherapy, radiation, and/or surgical intervention; long and documented PFAS exposure history (15+ years in firefighting or military); strong causation evidence including PFAS blood testing above 20 ng/mL |
| Tier 2 — Major Cancer | $100,000–$250,000 | Localized kidney cancer, testicular cancer, bladder cancer, non-Hodgkin lymphoma, or thyroid cancer requiring surgical resection and adjuvant therapy; documented intermediate PFAS exposure history (5–15 years); moderately elevated PFAS blood levels with supporting epidemiological evidence |
| Tier 3 — Moderate Cancer | $50,000–$100,000 | Prostate cancer, breast cancer, ovarian cancer, Hodgkin lymphoma, or leukemia with treatment and favorable prognosis; shorter or intermittent PFAS exposure history (1–5 years); moderate PFAS blood levels; weaker direct causation linkage but plausible epidemiological association |
| Tier 4 — Low-Severity / Early Stage | $15,000–$50,000 | Early-stage or in-situ cancers with surgical treatment and excellent prognosis; minimal PFAS exposure history (limited AFFF contact or low PFAS blood levels); or cancers with weaker scientific consensus on PFAS causation (e.g., multiple myeloma, pancreatic cancer without clear PFAS link) |
| Tier 5 — Pre-Cancer / Surveillance | $5,000–$15,000 | Pre-cancerous conditions or benign tumors requiring monitoring but no active cancer treatment; documented PFAS exposure without a formal cancer diagnosis but with elevated PFAS blood levels and associated medical monitoring costs; or claimants with borderline exposure documentation |
Key Statistics
Individual lawsuits pending in MDL No. 2873 as of mid-2026, including personal injury and water contamination claims
8,000+
3M settlement amount for PFAS drinking water contamination claims (June 2023), paid over 13 years to public water systems nationwide
$10.3B
DuPont and Chemours combined settlement for PFAS drinking water claims (2024–2025), resolving water provider lawsuits
$1.19B
Cancers for which IARC and scientific panels have found probable or possible links to PFAS exposure, including kidney, testicular, prostate, bladder, liver, thyroid, pancreatic, and non-Hodgkin lymphoma
8+
Number of PFAS chemicals identified in commerce and the environment, with PFOA and PFOS being the most studied and regulated
12,000+
Estimated number of Americans with PFAS detected in their drinking water at levels above the EPA's 2024 health advisory of 4 parts per trillion for PFOA and PFOS
200M+
Eligibility Criteria
To potentially qualify for an AFFF firefighting foam personal injury lawsuit, individuals should review the following criteria. Consultation with qualified legal counsel is necessary to determine eligibility in any specific case.
1. Worked as a firefighter (career, volunteer, or military) with documented exposure to AFFF during firefighting operations, training exercises, or equipment testing
2. Served in the U.S. military (Navy, Air Force, Army, Marine Corps, or Coast Guard) and were stationed at a facility where AFFF was used for fire training or aircraft rescue operations
3. Lived or worked near a military base, airport, or fire training facility where AFFF was used and PFAS was detected in local drinking water supplies above EPA health advisory levels
4. Been diagnosed with a cancer linked to PFAS exposure, including kidney cancer, testicular cancer, prostate cancer, bladder cancer, pancreatic cancer, liver cancer, thyroid cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, leukemia, multiple myeloma, ovarian cancer, or breast cancer
5. Have medical records documenting the qualifying cancer diagnosis and treatment history
6. Maintain records or evidence documenting the duration and frequency of AFFF exposure (employment records, military service records, facility assignments, training logs, or sworn affidavits)
7. Filed within the applicable statute of limitations (deadlines vary by state, typically 1–6 years from diagnosis or discovery of the link between PFAS and the injury)
How to File a Claim
Filing an AFFF firefighting foam lawsuit involves several stages, from initial case evaluation through MDL proceedings, settlement, or trial. The process below outlines the typical steps.
The first step is to complete a confidential case review with a legal matching service or directly with a law firm that handles AFFF MDL claims. You will be asked about your firefighting or military service history, your PFAS exposure background, your cancer diagnosis and treatment, and other relevant details. This is typically provided at no cost and without obligation.
If your case appears to meet basic eligibility criteria, you will be connected with an independent law firm that handles AFFF MDL claims. The law firm will gather your supporting documents—including military or employment records documenting AFFF exposure, medical records confirming your cancer diagnosis, and available PFAS blood testing results if applicable.
Once retained, the law firm will file a complaint on your behalf in federal court, where the case will be transferred to MDL No. 2873 in the District of South Carolina for coordinated pretrial proceedings. The defendants may include 3M, DuPont, Chemours, Tyco Fire Products, National Foam, Buckeye Fire Equipment, Kidde-Fenwal, and other AFFF manufacturers.
During discovery, both sides exchange evidence regarding PFAS toxicology, corporate knowledge of PFAS hazards, exposure pathway documentation, and causation expert testimony. The MDL has already completed significant discovery, and several bellwether trials have been conducted, providing settlement frameworks for resolving claims.
In June 2023, 3M agreed to a $10.3 billion settlement to resolve drinking water claims, and a separate $1.19 billion settlement was reached with DuPont/Chemours. Individual personal injury claims against these defendants are being resolved through the MDL settlement processes. Claims against remaining defendants continue to be litigated, with potential for additional settlements or trial outcomes.
Your legal team will manage all communications with defendants, attend MDL case management conferences, handle expert discovery and Daubert motion practice, and advise you on any settlement offers received. It is important to maintain open communication with your attorney and promptly respond to requests for documents or information.
Frequently Asked Questions
Sources & References
Think You May Have a Claim?
A free, confidential case review can help you understand your options and whether you may qualify for compensation. There is no obligation and no upfront cost.
Request a Free Case Review